These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 16981822)
21. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. Grenz A; Zhang H; Hermes M; Eckle T; Klingel K; Huang DY; Müller CE; Robson SC; Osswald H; Eltzschig HK FASEB J; 2007 Sep; 21(11):2863-73. PubMed ID: 17442731 [TBL] [Abstract][Full Text] [Related]
22. The role of vasoactive intestinal peptide in neuroprotection: Professor Illana Gozes is interviewed by Emma Quigley. Gozes I Expert Opin Ther Targets; 2007 Jun; 11(6):733-6. PubMed ID: 17504011 [TBL] [Abstract][Full Text] [Related]
23. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. Eckle T; Füllbier L; Wehrmann M; Khoury J; Mittelbronn M; Ibla J; Rosenberger P; Eltzschig HK J Immunol; 2007 Jun; 178(12):8127-37. PubMed ID: 17548651 [TBL] [Abstract][Full Text] [Related]
25. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Mizumoto N; Kumamoto T; Robson SC; Sévigny J; Matsue H; Enjyoji K; Takashima A Nat Med; 2002 Apr; 8(4):358-65. PubMed ID: 11927941 [TBL] [Abstract][Full Text] [Related]
26. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain. Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099 [TBL] [Abstract][Full Text] [Related]
27. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves. Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of CD39 protects in a mouse model of preeclampsia. McRae JL; Russell PA; Chia JS; Dwyer KM Nephrology (Carlton); 2013 May; 18(5):351-5. PubMed ID: 23600369 [TBL] [Abstract][Full Text] [Related]
30. Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium. Kaniewska-Bednarczuk E; Mielcarek M; Chester AH; Slominska EM; Yacoub MH; Smolenski RT Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):713-719. PubMed ID: 27906627 [TBL] [Abstract][Full Text] [Related]
31. Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition. Gendron FP; Benrezzak O; Krugh BW; Kong Q; Weisman GA; Beaudoin AR Curr Drug Targets; 2002 Jun; 3(3):229-45. PubMed ID: 12041737 [TBL] [Abstract][Full Text] [Related]
32. Widespread expression of ecto-apyrase (CD39) in the central nervous system. Wang TF; Guidotti G Brain Res; 1998 Apr; 790(1-2):318-22. PubMed ID: 9593967 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases. Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867 [TBL] [Abstract][Full Text] [Related]